Talis Biomedical Corporation TLIS
Set alert
2.84 USD +2.84 —
Day range unavailable
52-week range unavailable
- YTD
- 0.00%
- 1 year
- +71.08%
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 3.23M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.08
- Beta
- 1.56
- Short ratio
- 0.59
- Inst. own
- 55.06%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 24, 2024
- 50-d avg
- 1.89
- 200-d avg
- 6.59
- 1y target
- 0.00
2Y chart
Events in this range
- May 8, 2024Earnings: -7.15; estimate 0; surprise —%
- Aug 19, 2024Earnings: -4.86; estimate 0; surprise —%
- Dec 24, 2024Earnings: —; estimate 0; surprise —%
Signals (88)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Jan 9, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 18, 2025 | 10 months ago |
| RSI: Overbought | Dec 18, 2025 | 10 months ago |
| MACD: Sell Signal | Oct 30, 2025 | 1 year ago |
| SMA: Bullish | Oct 21, 2025 | 1 year ago |
| SMA: Bullish | Oct 21, 2025 | 1 year ago |
| RSI: Overbought | Oct 21, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 7, 2025 | 1 year ago |
| SMA: Bullish | Sep 24, 2025 | 1 year ago |
| SMA: Bearish | Sep 23, 2025 | 1 year ago |
| RSI: Oversold | Sep 23, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 10, 2025 | 1 year ago |
| SMA: Bearish | Sep 9, 2025 | 1 year ago |
| SMA: Bullish | Sep 4, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 4, 2025 | 1 year ago |
| RSI: Overbought | Sep 4, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 22, 2025 | 1 year ago |
| SMA: Bullish | Jul 31, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 24, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 27, 2025 | 1 year ago |
Newest 20 of 88.
Key statistics
- Market cap
- 3.23M
- Enterprise value
- -37.76M
- Trailing P/E
- 0.00
- Forward P/E
- -0.08
- PEG ratio
- 0.00
- Price / sales
- 7.91
- Price / book
- 0.07
- EPS (TTM)
- -28.02
- Beta
- 1.56
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 408.00K
- Revenue growth
- 0.00%
- Free cash flow
- -25.91M
- Total cash
- 59.87M
- Total debt
- 18.80M
- Return on equity
- -70.48%
- Shares outstanding
- 1.82M
- Short % of float
- 1.54%
- 50-day average
- 1.89
- 200-day average
- 6.59
Analyst view
Consensus: sell
Sell
Price target (mean) 0.00
Ratings (0m) 1 0 buy · 0 hold · 1 sell
- Strong buy0
- Buy0
- Hold0
- Sell0
- Strong sell1
Next earnings
Dec 24, 2024
Expected Dec 24, 2024. Consensus EPS estimate 0.00.
Financials — quick view
TLIS Revenue — quarterly 0
TLIS Net income — quarterly -8.85M
TLIS EPS — quarterly -4.86
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 24, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Aug 19, 2024 | Jun 1, 2024 | 0.00 | -4.86 | — | — |
| May 8, 2024 | Mar 1, 2024 | 0.00 | -7.15 | — | — |
| Mar 28, 2024 | Dec 1, 2023 | 0.00 | -7.39 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | -8.62 | — | — |
| Aug 10, 2023 | Jun 1, 2023 | 0.00 | -8.27 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 15, 2023 | BTIG | main | Sell | Sell |
About Talis Biomedical Corporation
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- talisbio.com
News
- Talis Biomedical (NASDAQ:TLIS) Shares Up 77.5% – Still a Buy?
- North American Morning Briefing : Global Ad Shares -2-
- Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
- Why Is Talis Biomedical (TLIS) Stock Down 52% Today?
- Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
- Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
- Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
- Stocks That Hit 52-Week Lows On Friday
- Stocks That Hit 52-Week Lows On Tuesday
Your note
Sign in to keep a note on TLIS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| LEONARD BRADEN MICHAEL | Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 5, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Greenlight Capital, Inc. | 8.19% | 149,053 | 71.55K | Jun 29, 2023 |
| Vanguard Group Inc | 1.71% | 31,090 | 14.92K | Jun 29, 2023 |
| Tudor Investment Corporation | 0.55% | 10,000 | 4.80K | Jun 29, 2023 |
| Geode Capital Management, LLC | 0.52% | 9,369 | 4.50K | Jun 29, 2023 |
| Millennium Management Llc | 0.34% | 6,098 | 2.93K | Jun 29, 2023 |
| Blackrock Inc. | 0.28% | 5,087 | 2.44K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.00% | 18,267 | 8.77K | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 0.68% | 12,452 | 5.98K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.29% | 5,205 | 2.55K | May 30, 2023 |
| Fidelity Total Market Index Fund | 0.11% | 1,953 | 957 | May 30, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.05% | 905 | 443 | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.05% | 978 | 479 | May 30, 2023 |